Content by Keyword: Outpatient Clinics, Hospital

  • Home
  • Outpatient Clinics, Hospital
  • print
  • email
  • twitter
  • compact
Basic report
Barriers to Implementing Technology in

Barriers to Implementing Technology in Residential Long-Term Care Settings

U.S. Department of Health and Human Services Barriers to Implementing Technology in Residential Long-Term Care Settings Vicki A. Freedman, Ph.D., Maggie Calkins, Ph.D., Robert DeRosiers, MS, OTR/L, ATP, and Kimberly Van Haitsma, Ph.D. Polisher Research Institute December 10, 2005 PDF Version: http://aspe.hhs.gov/daltcp/re
  • techbarr.pdf
    export-csvPDF
Basic report
Measuring the Activities of Daily Living:

Measuring the Activities of Daily Living: Comparisons Across National Surveys

U.S. Department of Health and Human Services Measuring the Activities of Daily Living: Comparisons Across National Surveys Joshua M. Wiener and Raymond J. HanleyThe Brookings Institution Robert Clark and Joan F. Van NostrandU.S. Department of Health and Human Services 1990 PDF Version: http://aspe.hhs.gov/daltcp/report
  • meacmpes.pdf
    export-csvPDF
Basic report
Literature Review and Synthesis of Physician

Literature Review and Synthesis of Physician Practices in Nursing Homes

U.S. Department of Health and Human Services Literature Review and Synthesis of Physician Practices in Nursing Homes Cari Levy, MD, Anne Epstein, PhD, Lori-Ann Landry, MSW, and Andrea Kramer, MD University of Colorado, Health Sciences Center Jennie Harvell, MEd, and Charlene Liggings, MPH, MPAU.S. Department of Health and Huma
  • phypraclr.pdf
    export-csvPDF
Basic report
Assessment and Care Planning for the Frail

Assessment and Care Planning for the Frail Elderly: A Problem Specific Approach

U.S. Department of Health and Human Services
  • asmtcare.pdf
    export-csvPDF
Analysis of the California In-Home Supportive

Analysis of the California In-Home Supportive Services (IHSS) Plus Waiver Demonstration Program

U.S. Department of Health and Human Services
Physician Practices in Nursing Homes: Final Report

Physician Practices in Nursing Homes: Final Report

U.S. Department of Health and Human Services
A Pilot Study fo the Adequacy of Post-Hospital

A Pilot Study fo the Adequacy of Post-Hospital Community Care for the Elderly: Final Report

U.S. Department of Health and Human Services
Interdisciplinary Education and Training of

Interdisciplinary Education and Training of Professionals Caring for Persons with Disabilities: Current Approaches and Implications for a Changing Health Care System

U.S. Department of Health and Human Services
Report page
The Diversity of Data Holders

Privacy and Health Research. The Diversity of Data Holders

Just as varied as the types of health data, of course, are the types of individuals and organizations who hold or process the data. Data are processed by:
Report page
Privacy and Confidentiality in Health Care(13)

Privacy and Health Research. Privacy and Confidentiality in Health Care(13)

An inevitable logical starting-point is the hallowed medical privacy tradition dating back at least as far as Hippocrates—but one doesn't have to be cynical to surmise that even Dr. H's own receptionist may have gossiped about patients' foibles and maladies.... The precept of nondisclosure is an ideal. But it has been, and should still be, centr
Report page
Drug Marketing Issues

Market Barriers to the Development of Pharmacotherapies for the Treatment of Cocaine Abuse and Addiction: Final Report. Drug Marketing Issues

Two market barriers related to drug marketing were identified. As previously described, the possibility of the pharmacotherapy being distributed through publicly-funded treatment centers rather than through physician offices was a concern of the pharmaceutical companies because of the companies' limited access to patients.
Report page
Patient Populations Perceived to Be Difficult to

Market Barriers to the Development of Pharmacotherapies for the Treatment of Cocaine Abuse and Addiction: Final Report. Patient Populations Perceived to Be Difficult to Study

Three of the four case study drugs were for patient populations perceived to be difficult to study for a variety of reasons (e.g., patient recruitment, compliance, and co-morbidities). For example, patient compliance has been seen as a barrier to the success of naltrexone in both the heroin addiction and alcoholism markets, because the drug is not
Report page
Critical Barrier 2: A Substance Abuse Treatment

Market Barriers to the Development of Pharmacotherapies for the Treatment of Cocaine Abuse and Addiction: Final Report. Critical Barrier 2: A Substance Abuse Treatment System that Limits Access to this Market

There was consensus among the pharmaceutical company representatives that the current substance abuse treatment system constitutes a great market barrier that severely limits opportunities for market penetration.
Report page
Case Study 4: Nicorette

Market Barriers to the Development of Pharmacotherapies for the Treatment of Cocaine Abuse and Addiction: Final Report. Case Study 4: Nicorette

Introduction Drug Overview
Report page
Case Study 2: Naltrexone

Market Barriers to the Development of Pharmacotherapies for the Treatment of Cocaine Abuse and Addiction: Final Report. Case Study 2: Naltrexone

Introduction Drug Overview
Report page
Case Study 1: LAAM

Market Barriers to the Development of Pharmacotherapies for the Treatment of Cocaine Abuse and Addiction: Final Report. Case Study 1: LAAM

Introduction Drug Overview
Report page
Summary of Case Study Results

Market Barriers to the Development of Pharmacotherapies for the Treatment of Cocaine Abuse and Addiction: Final Report. Summary of Case Study Results

The four case studies have several elements in common, particularly with regard to the target patient population. For example, three of the four drugs involve treatment for substance abuse including LAAM and naltrexone for heroin addiction, naltrexone for alcoholism, and Nicorette for smoking.
Report page
Market Penetration, Price, and Annual Revenue

Market Barriers to the Development of Pharmacotherapies for the Treatment of Cocaine Abuse and Addiction: Final Report. Market Penetration, Price, and Annual Revenue

In order to demonstrate basic relationships between market penetration, price, and annual revenue, the following analysis poses three levels of market penetration and three price levels for a new cocaine medication. The market penetration levels are "doubling," "saturation," and "half entry," as follows.
Report page
Objective 5.2 - Improve the Safety of Food,

HHS Strategic Goals and Objectives - FY 2001 . Objective 5.2 - Improve the Safety of Food, Drugs, Medical Devices, and Biological Products

How We Will Accomplish Our Objective We will access state-of-the-art science necessary for timely and credible regulatory decisions by: recruiting top scientists. engaging in continuous training of the professional work force.
Report page
Objective 1.6 - Reduce Unsafe Sexual Behaviors

HHS Strategic Goals and Objectives - FY 2001 . Objective 1.6 - Reduce Unsafe Sexual Behaviors

How We Will Accomplish Our Objective We will provide financial and technical assistance to a variety of community prevention services. Our priorities include: comprehensive state programs for the prevention of sexually transmitted diseases (STDs).

Pages

Form Approved OMB# 0990-0379 Exp. Date 9/30/2020